Fortune Health Study

???????????????????????????? ???????? ???????????????? ??????????????????? ?????????????????? ?????? ????????????????: https://lnkd.in/dDAVd-rR The global pharmaceutical drug delivery market, valued at US$1,831.1 billion in 2023, is forecasted to grow at a robust CAGR of 5.5%, reaching US$1,949.4 billion in 2024 and an impressive US$2,546.0 billion by 2029. North America dominates the pharmaceutical drug delivery market. This market is projected to reach USD 1,215.4 billion by 2029, at a CAGR of 5.0% during the forecast period. ????????????: Rising prevalence of chronic diseases ??????????????????: Risk of needlestick injuries ??????????????????????: Increased acceptance of self-administration and home care ??????????????????: Government Pricing pressure

?????? ?????????????? ???????????? ?????? ???????????????? ?????????????????????????? ???? ???????????????????? ?????? ???????????? ??????:https://lnkd.in/g3bGXeme The contract manufacturing market is booming across both medical devices and pharmaceuticals, driven by rising demand for high-quality, cost-effective production. ?? Pharmaceutical Contract Manufacturing ? 2023: US$183.6 billion ? 2024: US$200.9 billion ? 2029: US$319.6 billion ? CAGR: 9.7% ? Largest Market: North America ?? Medical Device Contract Manufacturing ? 2023: US$71.1 billion ? 2024: US$78.9 billion ? 2029: US$149.4 billion ? CAGR: 11.4% ? Largest Market: Asia Pacific ?? Key Players Shaping the Market ?? ? Flex | Jabil | TE Connectivity | Celestica | WuXi AppTec ? Thermo Fisher | Lonza | AbbVie | Sanmina | Catalent ? Samsung Biologics | Evonik | Merck | Integer | Benchmark With advancements in biopharma, medtech, and regulatory compliance, outsourcing to specialized contract manufacturers is becoming a strategic move for companies aiming for efficiency, scalability, and innovation. ?????? ???????????? ?????? ???? ?????????????? ???????????? ???????????????? ?????????????????????????? ????????????:https://lnkd.in/drRc3XtG #ContractManufacturing #MedicalDevices #Pharma #HealthcareInnovation #Biologics #MedTech

???????????????????? ?????????????????????? ???????????? ?????????????- ???????????? ???????????????? ???? 2030 ?????? ???????????? ??????:https://lnkd.in/ejpECJih The global healthcare information system market size is projected to reach USD 547.2 billion by 2030 from USD 290.4 Billion in 2022, at a CAGR of 8.2% during the forecast period. The healthcare information system market is mainly driven by factors such as rise in penetration of technological advanced healthcare services, increasing government initiatives, rise in healthcare expenditure and digitalization of the healthcare infrastructure. However, potential data security concerns related to healthcare information system are expected to restrain the growth of this market to a certain extent in the coming years. Major players operating in the healthcare information system market are McKesson Corporation (US), Cerner Corporation (US), athenahealth, Inc. (US), Allscripts Healthcare, LLC (US), Medidata Solutions Inc. (US), Agfa-Gevaert N.V. (Belgium),GE Healthcare (US), Siemens Healthineers (Germany), Epic Systems Corporation (US), NextGen Healthcare (US), eClinicalWorks (US), Philips Healthcare (Netherlands), Hewlett Packard (US), Carestream Health (US), Novarad Corporation (US), e-MDs Incorporation (US), Ada Health GmbH (Germany), SWORD Health (US), Siilo (Netherlands), Orion Health (US), Oracle (US), NXGN Management, LLC (US), Greenway Health, LLC (US), Infor (US) and Neusoft Medical Systems Co., Ltd. (China), among others.